A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has Not Progressed on First Line Platinum-Based Chemotherapy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The study is being conducted to evaluate the tolerability, safety and efficacy of maintenance Fluzoparib monotherapy in patients with gBRCA/PALB2 mutated metastatic pancreatic cancer whose disease has not progressed on first line platinum based chemotherapy.
Epistemonikos ID: c98d6aa7e2563cf5b28e506d4fd6e9ee3ac632eb
First added on: May 07, 2024